Biotech · Private company · Cambridge, MA, US

Tiba Biotech, LLC

Track this companyFree. Adds Tiba Biotech, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Lung-targeting delivery of small interfering RNA for pulmonary therapeuticsFiscal year 2026 · $396.8KNIH RePORTER 1R43HL184887-01A1 · fetched Nov 12, 2026
Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer ImmunotherapyFiscal year 2025 · $399.3KNIH RePORTER 1R43CA298492-01A1 · fetched Nov 12, 2026
Rapid response to pandemic influenza via multi-antigen RNA-based vaccineFiscal year 2025 · $965.7KNIH RePORTER 5R44AI167158-04 · fetched Nov 12, 2026
Rapid response to pandemic influenza via multi-antigen RNA-based vaccineFiscal year 2024 · $965.7KNIH RePORTER 5R44AI167158-03 · fetched Nov 12, 2026